Search results
Playbux Rolls Out Two New Upgrades to Make its Ecosystem More Universal and Rewarding
Digital Journal· 1 day ago...Corp in Revolutionary Room Temperature SPAD Technology TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC...
MedTech Outlook 2024 for Latin America Released
Digital Journal· 1 day ago...Corp in Revolutionary Room Temperature SPAD Technology TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC...
A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral...
Morningstar· 6 days agoSHELTON, CT / ACCESSWIRE / May 29, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, elaborates on its ...
Athena Bitcoin Global Announces CFO Transition
Digital Journal· 1 day ago...Corp in Revolutionary Room Temperature SPAD Technology TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 6 hours agoGHENT, Belgium, June 04, 2024 (GLOBE NEWSWIRE) -- ExeVir Bio, a biotech company developing robust heavy chain-only antibody therapies for broad protection against infectious diseases, today announced new data demonstrating that its antibodies
ONESTONE HOLDINGS Achieves Breakthrough in Green Hydrogen Production at Sea With Vertical Wind...
Digital Journal· 1 day ago...Corp in Revolutionary Room Temperature SPAD Technology TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC...
Novel CD40 Agonist-Chemo Combo Shows Promise in Pancreatic Cancer
MedPage Today· 2 days agoFrontline treatment with mitazalimab plus mFOLFIRINOX achieved responses in 40% of patients
Returns On Capital At Universal Health Services (NYSE:UHS) Have Hit The Brakes
Simply Wall St. via Yahoo Finance· 3 days ago1b) (Based on the trailing twelve months to March 2024). Therefore, Universal Health...
Punxsy downs defending state champs Riverside, 3-0
Jeffersonian Democrat· 5 hours agoThe Punxsutawney Chucks baseball team had revenge on its minds Monday at Showers Field in its PIAA Class 3A First Round matchup against WPIAL runner-up...
An Intrinsic Calculation For Sandfire Resources Limited (ASX:SFR) Suggests It's 27% Undervalued
Simply Wall St. via Yahoo Finance· 2 days ago1b The total value, or equity value, is then the sum of the present value of the future cash flows,...
